Olivier Tillement
Fondatore presso NH THERAGUIX SAS
Profilo
Olivier Tillement is the founder and director of NH TherAguix SAS, which is founded in 2015.
He is also the founder of Mexbrain SAS.
Currently, he holds the title of Professor at Université Claude Bernard Lyon 1.
Posizioni attive di Olivier Tillement
| Società | Posizione | Inizio |
|---|---|---|
| NH THERAGUIX SAS | Fondatore | 11/12/2015 |
Mexbrain SAS
 Mexbrain SAS Medical SpecialtiesHealth Technology Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation. | Fondatore | - |
| Université Claude Bernard Lyon 1 | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
NH TherAguix SAS
 NH TherAguix SAS Pharmaceuticals: MajorHealth Technology NH TherAguix SAS operates as a biotechnology company. The firm develops a nanodrug against cancer called AGuIX based on nanometric structuring that allows intravenous injection and the combination of the following properties to fight tumors: targeting, imaging, and treating. The company was founded by G?raldine Le Duc, Olivier Tillement and Fran?ois Lux in on December 11, 2015 and is headquartered in Meylan, France. | Health Technology |
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Olivier Tillement
